Terms: = Gastric cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
13 results:
1. H3K27 acetylation activated-CD109 evokes 5-fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway.
Zhou F; Wang L; Ge H; Zhang D; Wang W
Environ Toxicol; 2023 Dec; 38(12):2857-2866. PubMed ID: 37661780
[TBL] [Abstract] [Full Text] [Related]
2. An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.
Xing X; Jia S; Leng Y; Wang Q; Li Z; Dong B; Guo T; Cheng X; Du H; Hu Y; Feng Q; Lian S; Luan F; Ma X; Li Z; Ni M; Li Z; Ji J
Oncoimmunology; 2020 Aug; 9(1):1792038. PubMed ID: 32939321
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal cancer Based on Integrated Bioinformatics.
Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
[TBL] [Abstract] [Full Text] [Related]
4. [Real-world study on syndrome distribution and medication characteristics of colonic malignant tumors].
Wu LN; Xie YM; Liu H; Zhang Y; Lu Q; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1174-1179. PubMed ID: 32237462
[TBL] [Abstract] [Full Text] [Related]
5. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract] [Full Text] [Related]
6. gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection.
Matsuhisa T; Yamaoka Y; Uchida T; Duger D; Adiyasuren B; Khasag O; Tegshee T; Tsogt-Ochir B
World J Gastroenterol; 2015 Jul; 21(27):8408-17. PubMed ID: 26217093
[TBL] [Abstract] [Full Text] [Related]
7. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women.
Luo J; Chlebowski R; Liu S; McGlynn KA; Parekh N; White DL; Margolis KL
Cancer Causes Control; 2013 Mar; 24(3):577-85. PubMed ID: 22622863
[TBL] [Abstract] [Full Text] [Related]
8. [Plasmablastic lymphoma of the gastrointestinal tract in AIDS patients].
Avilés-Salas A; Herrera-Goepfert R; Aguilar-León D; Candelaria-Hernández M; Martínez-Cordero E; Corti M
Medicina (B Aires); 2011; 71(6):536-41. PubMed ID: 22167727
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract] [Full Text] [Related]
10. Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Lordick F; Luber B; Lorenzen S; Hegewisch-Becker S; Folprecht G; Wöll E; Decker T; Endlicher E; Röthling N; Schuster T; Keller G; Fend F; Peschel C
Br J Cancer; 2010 Feb; 102(3):500-5. PubMed ID: 20068568
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses.
Tillman GF; Pawlicki T; Koong AC; Goodman KA
Dis Esophagus; 2008; 21(5):437-44. PubMed ID: 19125798
[TBL] [Abstract] [Full Text] [Related]
12. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):335-43. PubMed ID: 17922276
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Gastric Cancer; 2007; 10(2):129-34. PubMed ID: 17577624
[TBL] [Abstract] [Full Text] [Related]
